Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04447755
What this trial is testing

Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Who this might be right for
Relapsed or Refractory Solid Tumors
Merck Sharp & Dohme LLC 127
Early research (Phase 1)Study completedNCT00143533
What this trial is testing

Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

Who this might be right for
NeoplasmDiarrhea
St. Jude Children's Research Hospital 20
Early research (Phase 1)Looking for participantsNCT06559189
What this trial is testing

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
University of Colorado, Denver 53
Testing effectiveness (Phase 2)Ended earlyNCT02227108
What this trial is testing

Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma

Who this might be right for
B-Cell Pediatric ALL
MedImmune LLC 37
Early research (Phase 1)Study completedNCT04888468
What this trial is testing

Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Who this might be right for
Acute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 9
Early research (Phase 1)Looking for participantsNCT07108868
What this trial is testing

A Phase I Dose Finding Study of MB-CART2219.1

Who this might be right for
LymphomaCLLAcute Lymphoblastic Leukemia, Pediatric
University Hospital Tuebingen 36
Early research (Phase 1)Ended earlyNCT05077423
What this trial is testing

Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML, Childhood
Y-mAbs Therapeutics 3
Early research (Phase 1)Looking for participantsNCT06760117
What this trial is testing

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

Who this might be right for
Pediatric Solid Tumor
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Looking for participantsNCT05645718
What this trial is testing

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06485908
What this trial is testing

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma

Who this might be right for
MedulloblastomaEpendymoma
Assistance Publique Hopitaux De Marseille 40
Very early researchStudy completedNCT03445858
What this trial is testing

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Who this might be right for
Childhood Solid TumorChildhood LymphomaRelapsed Cancer+3 more
Children's Hospital Medical Center, Cincinnati 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04268706
What this trial is testing

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

Who this might be right for
Hodgkin Lymphoma, AdultHodgkin Disease RecurrentHodgkin Disease Refractory+1 more
Tessa Therapeutics 97
Not applicableUnknownNCT06233526
What this trial is testing

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

Who this might be right for
Acute Myeloid Leukemia in Children
The Children's Hospital of Zhejiang University School of Medicine 60
Testing effectiveness (Phase 2)Looking for participantsNCT05457829
What this trial is testing

Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study

Who this might be right for
Rhabdomyosarcoma, Child
Sun Yat-sen University 88
Testing effectiveness (Phase 2)Ended earlyNCT00439296
What this trial is testing

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Who this might be right for
Recurrent Pediatric ALLRelapsed Pediatric ALLAcute Lymphoblastic Leukemia+1 more
Therapeutic Advances in Childhood Leukemia Consortium 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT03703050
What this trial is testing

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)

Who this might be right for
Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 45
Testing effectiveness (Phase 2)Study completedNCT02544789
What this trial is testing

Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Betta Pharmaceuticals Co., Ltd. 44
Early research (Phase 1)Study completedNCT01048892
What this trial is testing

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Who this might be right for
Adrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more
Children's Oncology Group 22
Not applicableLooking for participantsNCT05588063
What this trial is testing

TaVNS for FRNS in Children

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 30
Early research (Phase 1)Study completedNCT01900509
What this trial is testing

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaAcute Leukemia
St. Jude Children's Research Hospital 16
Next Page